Fairmont Hotel Vancouver Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Fatty Liver Disease and Multi-System Complications  (X5)

joint with the meeting on Hepatobiliary Cancers: Pathobiology and Translational Advances (X6)

Scientific Organizers: Jay D. Horton, Morris J. Birnbaum and Hannele Yki-Järvinen


March 21—24, 2021

Fairmont Hotel Vancouver, Vancouver, BC, Canada


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

** Registration opens in January 2020 **



Discounted Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is )

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is )

Discounted Registration Deadline: January 20, 2021

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, March 21 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, March 24 with a closing plenary session from 14:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Thursday, March 25 in order to fully experience the meeting.

SUNDAY, MARCH 21

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


MONDAY, MARCH 22

07:00—08:00
Breakfast

08:00—09:30
Welcome and Keynote Session (Joint)
Registered attendees can view abstracts starting on 02/21/2021

Helen H. Hobbs, University of Texas Southwestern Medical Center, USA
PNPLA3's Role in NAFLD

Hashem B. El-Serag, Baylor College of Medicine, USA
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

09:30—09:50
Coffee Break

09:30—11:30
Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers (Joint)
Registered attendees can view abstracts starting on 02/21/2021

Lopa Mishra, George Washington University, USA
TGF-beta Signaling in Liver Fibrosis and Hepatocellular Carcinoma

Sangeeta N. Bhatia†, Massachusetts Institute of Technology, USA
In situ Expansion of Engineered Human Liver Tissue in a Mouse Model of Chronic Liver Disease

Short Talks Chosen from Abstracts

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
Genetics of NAFLD
Registered attendees can view abstracts starting on 02/21/2021

Elizabeth K. Speliotes, University of Michigan, USA
Use of GWAS to Identify SNPs Associated with NAFLD

Hannele Yki-Järvinen, University of Helsinki, Finland
Effects of Genetic Risk Factors for NAFLD on Hepatic Lipid Metabolism

Noura S. Abul-Husn†, Icahn School of Medicine at Mount Sinai, USA
Mutations in 17ß-HSD13 and Protection from NASH

Short Talks Chosen from Abstracts

17:00—19:00
The Role of the Microbiome in Hepatobiliary Cancers
Registered attendees can view abstracts starting on 02/21/2021

Speaker to be Announced

Yinying Lu, Tsinghua University, China
China’s Innovative Practice on Precision Immunotherapy of Hepatobiliary Carcinoma: From Outcome Prediction to New Therapeutic Approaches

Laurence Zitvogel†, Institut Gustave Roussy, France
The Gut Microbiome and Anti-Cancer Immunosurveillance

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


TUESDAY, MARCH 23

07:00—08:00
Breakfast

08:00—11:00
Role of Lipids in NAFLD
Registered attendees can view abstracts starting on 02/21/2021

Mitchell A. Lazar, Perelman School of Medicine, University of Pennsylvania, USA
Circadian Contributions to NAFLD

Daniel A. Heller, Memorial Sloan Kettering Cancer Center, USA
Lipid Dysregulation in Inflammation, NASH, and Cancer

Coffee Break

Catherine Postic, INSERM, Institut Cochin, France
Altered Insulin Signaling and Glucose Toxicity in NAFLD

Tobias C. Walther, Harvard School of Public Health, USA
Lipid Droplet Biology in NAFLD

Short Talks Chosen from Abstracts

08:00—11:00
Tumor Microenvironment and Hepatobiliary Cancers
Registered attendees can view abstracts starting on 02/21/2021

Silvia Affo, Columbia University, USA
The Role of Cancer-Associated Fibroblasts in the Pathogenesis of Hepatobiliary Cancers

Amaia Lujambio, Icahn School of Medicine at Mount Sinai, USA
Mechanisms of Immune Escape in Hepatocellular Carcinoma

Coffee Break

Alphonse E. Sirica, Virginia Commonwealth University, USA
The Desmoplastic Reaction in Intrahepatic Cholangiocarcinoma: Molecular Drivers and Prognostic Implications

Gregory J. Gores, Mayo Clinic, USA
Targeting the Tumor Microenvironment for Cholangiocarcinoma Therapy

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
NAFLD and CVD
Registered attendees can view abstracts starting on 02/21/2021

Aaron Isaacs†, Maastricht University, Netherlands
Relationship between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease

Jay D. Horton, University of Texas Southwestern Medical Center, USA
Molecular Mediators of NAFLD and Hyperlipidemia

Henry N. Ginsberg, Columbia University College of Physicians and Surgeons, USA
Loss of Function of TorsinA, an ER Localized AAA ATPase Causes Severe Steatosis with Decreased VLDL Secretion and Abnormal ER Lipid Droplets

Short Talks Chosen from Abstracts

17:00—19:00
Hepatobiliary Cancer Biomarkers
Registered attendees can view abstracts starting on 02/21/2021

Yujin Hoshida, UT Southwestern Medical Center, USA
Liver Cancer Risk-Predictive Molecular Biomarkers Specific to Clinico-Epidemiological Contexts

Irene Oi Lin Ng†, University of Hong Kong, Hong Kong
Non-Coding RNAs in Liver Cancer

Augusto Villanueva Rodriguez, Icahn School of Medicine at Mount Sinai, USA
Liquid Biopsy in Hepatobiliary Cancers

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


WEDNESDAY, MARCH 24

07:00—08:00
Breakfast

08:00—11:00
Pathways to NASH
Registered attendees can view abstracts starting on 02/21/2021

Speaker to be Announced

Mark A. McNiven, Mayo Clinic, USA
Lipid Droplet Formation and Lipophagy in Fatty Liver Disease

Coffee Break

Eran Elinav, Weizmann Institute of Science, Israel
Lipid-Associated Macrophages Control Metabolic Homeostasis

Speaker to be Announced

Short Talks Chosen from Abstracts

08:00—11:00
Genomic and Epigenomic Heterogeneity in Hepatobiliary Cancers
Registered attendees can view abstracts starting on 02/21/2021

Xin Wei Wang, NCI, National Institutes of Health, USA
Causes and Functional Intricacies of Intertumor and Intratumor Heterogeneity in Primary Hepatobiliary Cancers

Jessica Zucman-Rossi, University Paris Descartes-HEGP, France
Molecular Subtypes of Hepatocellular Carcinoma are Related to Specific Tumor Phenotypes

Coffee Break

Renumathy Dhanasekaran, Stanford University, USA
Complexities of Genetic Heterogeneity in Hepatocellular Carcinoma

Bin Tean Teh, Duke-NUS Medical School, Singapore
Cholangiocarcinoma in Diverse Populations

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:00—16:00
Emerging Therapies for NASH-I
Registered attendees can view abstracts starting on 02/21/2021

Morris J. Birnbaum, Pfizer Inc., USA
DGAT2 Inhibition for NASH

Speaker to be Announced

Greg Steinberg, McMaster University, Canada
Cellular Energy Sensors and Metabolism

Short Talks Chosen from Abstracts

14:30—16:30
"Omics" for Precision Medicine of Hepatobiliary Cancers
Registered attendees can view abstracts starting on 02/21/2021

Josep Llovet, Icahn School of Medicine at Mount Sinai, USA
Integrative "Omics" and Precision Medicine for Hepatocellular Carcinoma

Jesper Bøje Andersen, University of Copenhagen, Denmark
Defining Distinct Subtypes of Intrahepatic Cholangiocarcinoma by Molecular Profiling: Diagnostic, Prognostic, and Therapeutic Applications

Robert F. Schwabe, Columbia University, USA
Discovery of Subgroup-Specific HCC Master Regulators by Systems Biology Approaches

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—18:45
Emerging Therapies for NASH-II
Registered attendees can view abstracts starting on 02/21/2021

Kendra K. Bence, Pfizer Inc., USA
Inhibition of Fructose Metabolism for the Treatment of NAFLD

Chuhan Chung†, Yale University School of Medicine, USA
ACC Inhibitors for NASH

Lei Ling, NGM Biopharmaceuticals, USA
Therapeutic FGF19 in Non-alcoholic Steatohepatitis

Short Talks Chosen from Abstracts

17:00—18:45
Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Registered attendees can view abstracts starting on 02/21/2021

Bruno Sangro, Clinica Universidad de Navarra, Spain
Targeted Agent and Immune-Based Therapies for Hepatocellular Carcinoma

Tim F. Greten, NCI, National Institutes of Health, USA
Immunotherapies for Hepatobiliary Cancers: Current Status and Future Perspectives

R. Kate Kelley†, University of California, San Francisco, USA
Developing Clinical Trials of Novel Therapeutic Agents and Treatment Combinations for Intrahepatic Cholangiocarcinoma

Short Talks Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/21/2021

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/21/2021

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


THURSDAY, MARCH 25

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179